Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

Challenging cases on mitral interventions, TAVI and LAA closure

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!

Morning cases

Abstracts in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!

Abstracts in Japanese

Challenging cases

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover challenging TAVI cases and high-risk procedures, regarding pulmonic valve stenosis and PPM, calcific aortic stenosis, degenerative aortic stenosis, and more. Watch it now to discover the chosen treatment!

Challenging cases

TAVI and others

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.

TAVI and others

Complication cases

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.

Complication cases

Session for the Co-medicals in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!

Session for the Co-medicals in Japanese

Imaging Day - Case-based echo imaging for the aortic valve

14 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about low-flow low-gradient aortic stenosis, and discover how to predict prothesis-patient mismatch and how to detect prosthetic valve thrombosis.

Imaging Day - Case-based echo imaging for the aortic valve

PCR and TCT announce the creation of a New Educational Program: Partners in Learning

21 Jan 2020

New York, NY – Tuesday 21, 2020 – PCR and TCT are proud to announce the creation of a new educational program: “Partners in Learning”. The first of its kind will focus on TAVI practitioners, taking place on 21-22 March 2020 in Sao Paulo, Brazil. It...

PCR and TCT announce the creation of a New Educational Program: Partners in Learning

Best of PCRonline in 2019

13 Jan 2020

Thank you to the thousands of cardiologists and healthcare professionals whose contribution to the website provides the community with a valuable, free resource of education in cardiovascular interventions - this embodies the By and For that sets PCRonline apart! Thanks to you, over half a million...

Best of PCRonline in 2019

My five top trials in interventional cardiology in 2019: impact on clinical practice?

02 Jan 2020 – From GulfPCR-GIM 2020

Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!

My five top trials in interventional cardiology in 2019 and their impact on clinical practice

Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses (CoreValve US Expanded Use Study)

31 Dec 2019

Valve-in-valve transcatheter aortic valve implantation (VIV TAVI) over the last few years has been regarded as a reasonable treatment option for patients with failed surgical bioprostheses who are at increased risk for surgical reoperation and suitable anatomical features. While VIV TAVI showed good short-term hemodynamic and...

Dejan Milasinovic

Reviewer

Dejan Milasinovic
M. Pighi

Reviewer

Michele Pighi
Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses

Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in Transcatheter Aortic Valve Replacement (EASY TAVI)

23 Dec 2019

This study reports the results of using the Left ventricular (LV) guidewire for pacing instead of introducing a temporary RV pacing wire. The safety of this approach is weighed against the potential complications of temporary pacing wires that include access and right ventricular perforation.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Ki Park

Reviewer

Ki Park
Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in TAVR

Determining the predominant lesion in patients with severe aortic stenosis and coronary stenoses: A multicenter study using intracoronary pressure and flow

20 Dec 2019

Concomitant coronary artery disease (CAD) is frequently found in patients with severe aortic stenosis (AS) undergoing treatment with transcatheter aortic valve implantation (TAVI).

Nicola Ryan

Reviewer

Nicola Ryan
Determining the predominant lesion in patients with severe aortic stenosis and coronary stenoses

Shaping the future of transcatheter valve interventions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Shaping the future of transcatheter valve interventions

Interactive Case Corner 9 - Complex TAVI & PCI

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover a selection of complex PCI and TAVI cases, such as TAVR in low-lying coronary ostium and narrow sinus of valsalva, complex left main primary PCI for a patient with cardiogenic shock, renal disease with bilateral critical renal artery stenosis, and more!

Interactive Case Corner 9 - Complex TAVI & PCI

Updates in TAVI therapies

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.

Updates in TAVI therapies

Early surgery or conservative care for asymptomatic aortic stenosis (RECOVERY)

13 Dec 2019

The RECOVERY trial sought to compare long-term clinical outcomes of early surgical AVR with conservative care strategy according to the current guidelines in asymptomatic patients with very severe AS.

Reviewer

Salvatore Brugaletta

Reviewer

Ali Nazmi Calik
RECOVERY: Early surgery or conservative care for asymptomatic aortic stenosis

A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)

13 Dec 2019

The GALILEO trial was a randomized, open-label, event-driven, international, multicentre trial comparing two different preventive strategies for thromboembolic complications in patients who underwent successful TAVI and had not established indication for oral anticoagulation.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Eduardo Bahena-López

Reviewer

Eduardo Bahena-López
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

TAVI and Coronary access

11 Dec 2019

Watch the video on demand with Lars Sondergaard, Giuseppe Tarantini and Thierry Lefevre

PCR Webinar Round Table on TAVI and Coronary access

Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease

06 Dec 2019

This study compared the outcomes of TAVR in patients with pure Aortic Stenosis (i.e., without or trivial AR) vs. patients with MAVD (AS associated with mild to moderate or severe AR).

Babu Ezhumalai

Reviewer

Babu Ezhumalai

Reviewer

Salvatore Brugaletta
Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease